Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice

Clinics and Practice

Teresa Aseret-Manygoats¹  Tenneh Turner-Warren¹  John Ehiri²  Aminata Kilungo²  Sally Riggs²  David R. Axon³  Sonia Morales³  Becka Eckert³  Jennifer M. Bingham³  Megan Grieser³  Nicole Scovis³  Jim Kloster³  Terri Warholak³ 

[1] Arizona Department of Health Services, Phoenix, AZ 85007, USA;Mel and Enid Zuckerman College of Public Health, University of Arizona Mel, Tucson, AZ 85724, USA;R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA;

关键词: medication therapy management;    telehealth;    rural health;    pharmacist;   

DOI  :  10.3390/clinpract12030029

来源: DOAJ

【 摘 要 】

This study evaluated a pharmacist-led telephonic Medication Therapy Management (MTM) program for rural patients in Arizona with poor access to healthcare services. A pharmacist provided telephonic MTM services to eligible adult patients living in rural Arizona communities with a diagnosis of diabetes and/or hypertension. Data were collected and summarized descriptively for demographic and health conditions, clinical values, and medication-related problems (MRPs) at the initial consultation, and follow-up data collected at 1 and 3 months. A total of 33 patients had baseline and one-month follow-up data, while 15 patients also had three-month follow-up data. At the initial consultation, the following MRPs were identified: medication adherence issues, dose-related concerns, adverse drug events (ADE), high-risk medications, and therapeutic duplications. Recommendations were made for patients to have the influenza, herpes zoster, and pneumonia vaccines; and to initiate a statin, angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, and/or rescue inhaler. In conclusion, this study demonstrated that while pharmacists can identify and make clinical recommendations to patients, the value of these interventions is not fully realized due to recommendations not being implemented and difficulties with patient follow-up, which may have been due to the COVID-19 pandemic. Additional efforts to address these shortcomings are therefore required.

【 授权许可】

Unknown